Colorectal Polyp - Pathology Reporting Concepts

Key Points

• Polyp type and dysplasia grade determine cancer risk.
• Conventional adenoma and serrated lesions are distinct precursor pathways.
• Adenoma size at least 10 mm, high-grade dysplasia, and villous features increase surveillance intensity.
• Sessile serrated lesions require accurate distinction from hyperplastic polyps.
• Malignant polyps require assessment of invasion, margin, lymphovascular invasion, grade, and budding.
• Piecemeal resection limits margin interpretation and increases local recurrence risk.
• Surveillance interval depends on the whole colonoscopy, not pathology alone.
• Numerous adenomas can signal a hereditary polyposis syndrome.

Algorithm

1. Classify the polyp using current WHO/CAP terminology.
2. Report dysplasia and invasive carcinoma when present.
3. For malignant polyps, document margin and other high-risk histologic features.
4. Correlate pathology with endoscopic size, number, location, and resection technique.
5. Apply post-polypectomy surveillance guidance using the complete colonoscopy findings.
6. Arrange early site check after large piecemeal resection when indicated.
7. Refer malignant high-risk polyps for colorectal surgical review.
8. Consider genetic evaluation for high cumulative adenoma burden or syndromic features.

Clinical Synopsis & Reasoning

Colorectal polyps include conventional adenomas, serrated lesions, inflammatory polyps, hamartomas, and other entities with different cancer risk. Conventional adenomas are classified as tubular, tubulovillous, or villous and graded for dysplasia. Advanced neoplasia features include size at least 10 mm, high-grade dysplasia, or substantial villous architecture. Sessile serrated lesions are a distinct precursor pathway and can be difficult to recognize histologically when orientation is poor.

Pathologists should use standardized terminology and avoid older ambiguous labels when current entities are more precise. Hyperplastic polyps are usually low risk when small and distal, while sessile serrated lesions, particularly larger or proximal lesions and those with dysplasia, carry greater future neoplasia risk. Traditional serrated adenoma is less common but is a true premalignant lesion.

If invasive adenocarcinoma is present within a polyp, management depends on whether invasion is limited to submucosa and whether adverse histologic features are present. Important elements include depth and extent of invasion where applicable, grade, lymphovascular invasion, tumor budding, margin distance, and fragmentation. A piecemeal specimen can make margin assessment impossible. Intramucosal carcinoma in the colorectum does not carry the same lymph-node metastatic risk as true submucosal invasion and terminology should be clear.

Treatment Strategy & Disposition

Surveillance recommendations are made from the entire colonoscopy, not pathology in isolation. The endoscopist provides number, size, location, completeness of resection, bowel-preparation quality, and whether removal was en bloc or piecemeal. The U.S. Multi-Society Task Force uses these variables to determine intervals. One or two small tubular adenomas have a substantially longer follow-up interval than multiple adenomas, an adenoma at least 10 mm, high-grade dysplasia, or a large serrated lesion.

Large lesions removed piecemeal often require early site reassessment because residual tissue is more likely. A malignant polyp with favorable features and a clear margin may be adequately treated endoscopically in selected patients, whereas lymphovascular invasion, poor differentiation, significant budding, deep invasion, or an involved/uncertain margin can prompt surgical colectomy with lymph-node assessment.

Pathology and endoscopy must be reconciled. If the endoscopist documents a 15-mm lesion but pathology contains only tiny fragments, size should come from the endoscopic measurement rather than summing fragments. Conversely, a pathology report that identifies a sessile serrated lesion should trigger review of location and completeness of removal. High adenoma burden can warrant genetic evaluation, especially in younger patients.

Epidemiology / Risk Factors

• Adenomatous and serrated polyps are common, especially with increasing age.
• Screening and polypectomy reduce colorectal cancer incidence and mortality.
• Most small polyps will never become invasive cancer.
• Risk rises with cumulative adenoma burden and advanced histologic features.

Investigations

High Risk Features

Pharmacology

Prognosis / Complications

• Completely removed low-risk polyps have an excellent prognosis.
• Large, high-grade, villous, or serrated lesions predict greater future neoplasia risk.
• Malignant polyp prognosis depends on nodal-metastatic risk features and adequacy of excision.
• Adherence to surveillance prevents a substantial portion of interval cancers.

Patient Education / Counseling

• Tell patients that the pathology type helps determine when the next colonoscopy is needed.
• Explain that an 'adenoma' is precancerous, not cancer.
• If a malignant focus is found, clarify whether additional surgery is recommended and why.
• Encourage patients to keep the colonoscopy and pathology reports together because size and number come from the procedure while histology comes from pathology.
• Family members may need earlier screening when hereditary risk is suspected.

Notes

A useful pathology report supports the surveillance decision but does not make that decision alone. The endoscopist's count, measured size, preparation quality, and completeness of removal are equally important.

When invasive cancer is present, terminology should clearly distinguish a malignant polyp from high-grade dysplasia. That distinction changes whether lymph-node staging and colectomy are considered.

References

1. College of American Pathologists: Current Cancer Protocols — Link
2. U.S. Multi-Society Task Force: Follow-up After Colonoscopy and Polypectomy — Link